Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings

Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings

Abstract Background Peripheral diagnostics for Alzheimer’s disease (AD) continue to be developed. Diagnostics capable of detecting AD before the onset of symptoms are particularly desirable, and, given the fact that early detection is imperative for alleviating long-term symptoms of the disease, met...

Full description

Bibliographic Details
Main Authors: Marwan N Sabbagh, Jiong Shi, Moonhee Lee, Lisa Arnold, Yazan Al-Hasan, Jennifer Heim, Patrick McGeer
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Neurology
Subjects:
Alzheimer’s disease
Beta amyloid
Biomarker
Dementia
Saliva
Online Access:http://link.springer.com/article/10.1186/s12883-018-1160-y

Internet

http://link.springer.com/article/10.1186/s12883-018-1160-y

Similar Items